ISO 22442:2007
ISO 22442:2007 Medical devices utilizing animal tissues and their derivatives – Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
CDN $263.00
Description
ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.
Edition
1
Published Date
2007-11-27
Status
PUBLISHED
Pages
22
Language
English
Format
Secure PDF
Secure – PDF details
- Save your file locally or view it via a web viewer
- Viewing permissions are restricted exclusively to the purchaser
- Device limits - 3
- Printing – Enabled only to print (1) copy
See more about our Environmental Commitment
Abstract
ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.
Previous Editions
Can’t find what you are looking for?
Please contact us at:
Related Documents
-
ISO 10993:2020 Biological evaluation of medical devices – Part 19: Physico-chemical, morphological and topographical characterization of materials
CDN $195.00 Add to cart -
ISO 20776:2019 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices – Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
CDN $263.00 Add to cart -
ISO 22442:2020 Medical devices utilizing animal tissues and their derivatives – Part 1: Application of risk management
CDN $263.00 Add to cart -
ISO 10993:2023 Biological evaluation of medical devices – Part 55: Interlaboratory study on cytotoxicity
CDN $263.00 Add to cart
